ESC Premium Access

Inhibition of microRNA-210 as a novel therapeutic strategy to protect against atherosclerosis development

Topic: Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis

Presentation

About the speaker

Doctor Nicoleta Alexandru

Institute of Cellular Biology and Pathology 'Nicolae Simionescu', Bucharest (Romania)
0 follower

10 more presentations in this session

Deficiency of the long noncoding RNA NEAT1 disturbs T cell and monocyte-macrophage lineage differentiation and functions and results in systemic inflammation with high circulating interferon levels

Speaker: Professor W. Poller (Berlin, DE)

Thumbnail

Whole transcriptome sequencing to define monocyte subpopulation-specific lncRNA profiles in acute myocardial infarction patients and healthy controls

Speaker: Doctor A. Kratzer (Berlin, DE)

Thumbnail

Exercise-induced miR-17-3p Prevents Pathological Myocardial Dysfunction

Speaker: Doctor Q. Zhou (Shanghai, CN)

Thumbnail

CRISPR/Cas9 mediated miR-29b editing restores muscle atrophy and exercise capacity in mice

Speaker: Doctor J. Li (Shanghai, CN)

Thumbnail

Mesenchymal stem cells derived from bone marrow promotes cardiomyocytes survival under hypoxia through exosomal miR-210

Speaker: Mr H. Cheng (Shanghai, CN)

Thumbnail

Access the full session

Poster Session 6 - Non-coding RNAs

Speakers: Doctor N. Alexandru, Professor W. Poller, Doctor A. Kratzer, Doctor Q. Zhou, Doctor J. Li...
Thumbnail

About the event

Image

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

This platform is supported by

logo Novo Nordisk